Fundamental studies of Cefixime(CFIX) in Mxillofacial surgery.
-
- MOTOJI SHIGEKI
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- TAKENONO IWAO
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- OHTSUKA YOSHIKI
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- NAKASUJI KANAKO
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- HIRANO FUKI
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- KOBAYASHI SOUICHIROU
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- SANO EISAKU
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- YOSHII TAKASHI
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- NAKAO KAORU
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
-
- SHIMADA KEIKICHI
- Department of Mexillofacial Surgery, School of Medicine, Kobe University
Bibliographic Information
- Other Title
-
- Cefixime(CFIX)の口腔外科領域における基礎的検討
Search this article
Abstract
We carried out fundamental studies to evaluate the usefulness of Cefixime (CFIX) in maxillofacial surgery, and obtained the following results.<BR>1) The mean values of concentrations of CFIX after administration of 200mg P.O. to non-fasted patients were 2.42μg/ml (5 hr), 1.79μg/ml (7 hr) in serum, 0.95μg/ml (5 hr), and 0.65μg/ml (7 hr) in blood in wound. Gingival concentrations of CFIX were 0.21-1.17μg/g except 6 N.D.<BR>2) The antibacterial activity of CFIX against 65 Streptococcus sp. clinically isolated was equivalent to those of Ampicillin (ABPC), Cefteram (CFTM), Cefuroxime (CXM) Ofloxacin (OFLX) and superior to that of Cefaclor (CCL) at MIC80, but against 30 Staphyloccoccus sp. CFIX showed inferior antibacterial activity to other antibiotics. Among all antibiotics, CFIX showed the strongest antibactrial activity against arerobic gram-negative organisms.<BR>3) It was considered that CFIX was effective in the treatment of mild and moderate oral infections.
Journal
-
- ORAL THERAPEUTICS AND PHARMACOLOGY
-
ORAL THERAPEUTICS AND PHARMACOLOGY 11 (1), 1-8, 1992
JAPANESE SOCIETY OF ORAL THERAPEUTICS AND PHARMACOLOGY
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204728218496
-
- NII Article ID
- 130004040346
-
- ISSN
- 18844928
- 02881012
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed